GlassScriptPhysician profile
Emma I Stout
NPI 1639308828
$1,453.54
in general payments reported to CMS, 2019-2025
19 companies · $13.68 in 2025
The $13.68 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $138 · 2021: $448 · 2022: $93.61 · 2023: $363 · 2024: $262 · 2025: $13.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $638.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $242.82 | 2021-2024 | Abre, Venaseal |
| Astrazeneca Pharmaceuticals LP | $235.83 | 2020-2025 | Farxiga, Breztri |
| Bard Peripheral Vascular, INC. | $159.39 | 2021 | |
| Novo Nordisk INC | $157.30 | 2020-2023 | Ozempic, Rybelsus |
| Abbott Laboratories | $111.11 | 2023-2024 | Jeti All In One Non-Sterile Kit, Freestyle Libre 2 |
| Boston Scientific Corporation | $102.86 | 2019-2021 | |
| Medtronic Vascular, INC. | $77.46 | 2019-2020 | |
| Pfizer INC. | $75.61 | 2023-2024 | |
| Idorsia Pharmaceuticals US INC | $56.59 | 2023-2024 | Quviviq |
| Biohaven Pharmaceuticals, INC. | $52.84 | 2021 | |
| Janssen Pharmaceuticals, INC | $44.46 | 2021 | |
| Tactile Systems Technology INC | $26.04 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $21.66 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.43 | 2020 | |
| Paratek Pharmaceuticals, INC. | $16.02 | 2023 | Nuzyra |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $15.04 | 2020 | |
| Inogen, INC. | $14.55 | 2022 | |
| Nestle Healthcare Nutrition INC. | $13.62 | 2023 | |
| Lilly USA, LLC | $12.91 | 2023 | Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emma Stout listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.